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Background: Misoprostol has become a popular over the counter self-administered abortifacient in Ghana. This
study aimed to compare the socio-demographic characteristics and clinical complications associated with
misoprostol and non-misoprostol induced abortions among patients admitted to a tertiary public health facility
in Ghana.
Methods: This was a cross sectional study conducted at the gynaecological ward of Komfo Anokye Teaching
Hospital (KATH), over a four-month period using a structured pre-tested questionnaire. Data were analysed using
Chi-square, Fisher’s exact and student t-tests. Factors associated with severe morbidity were examined using Poisson
regression with robust error variance to estimate crude and adjusted relative risks (RRs) with 95% confidence
intervals (CIs). P < 0.05 was considered statistically significant.
Results: Overall, 126 misoprostol users and 126 misoprostol non-users were recruited into the study. About 71%
of the clients had self-induced abortions. Misoprostol users were more likely to be younger (p < 0.001), single
(p < 0.001), nulliparous (p = 0.001), of higher educational background (p = 0.001), and unemployed (p < 0.001), than
misoprostol non-users. Misoprostol users were more likely than non-users to undergo termination of pregnancy
because they wanted to continue schooling (p < 0.001) or were not earning regular income to support a family
(p = 0.001). Overall, 182 (72.2%) of the women (79.4% misoprostol users vs. 65.1% misoprostol non-users; p = 0.01)
suffered severe morbidity. Nulliparous women (adjusted RR, 1.28; 95% CI, 1.08-1.52) and those who had induced
abortion after 12 weeks’ gestation (adjusted RR, 1.36; 95% CI, 1.18-1.57) were at increased risks of experiencing
severe morbidity. The association between mode of abortion induction and severe morbidity was not statistically
significant (p = 0.06).
Conclusion: Self-induced abortions using misoprostol is a common practice among women in this study; nearly
three quarters of them suffered severe morbidity. Nonetheless, severe morbidity among misoprostol users and
non-users did not differ significantly but was directly related to the gestational age at which the induced abortions
occurred. Health education on the dangers of self-induced abortions and appropriate use of medication abortion
could help reduce complications associated with induced abortions in Ghana.
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Each year an estimated 20% (~42 million) of all pregnan-
cies worldwide end in induced abortions, 20 million of
which are performed under unsafe conditions [1,2]. Thir-
teen per cent of maternal deaths worldwide are attribut-
able to unsafe abortions, most of them in developing
countries [1,3]. Additionally, an estimated five million
women in developing countries are hospitalized each year
with complications of induced abortions [4]. Unsafe
abortions are frequently carried out by individuals lack-
ing the necessary skill and sometimes self-induced. Africa
has one of the highest induced-abortion rates in the
world (29 per 1000 women of reproductive age) and
more than 90% of these are unsafe [1,2]. These induced
abortion rates tend to be higher in settings with high un-
met need for contraception and are likely to keep rising
unless women’s access to effective contraception and safe
abortion care are improved [1].
The abortion law in Ghana was amended in 1985 to
make it more liberal. The current law permits abortion
carried out by a registered medical practitioner in a reg-
istered public or private health facility under the follow-
ing circumstances: rape, defilement and incest; where
the pregnancy poses substantial risk to the physical or
mental health of the woman; or in cases of severe fetal
anomaly [5,6]. In 2003, a policy to provide abortion care
to the full extent of the law was developed. And since
2006, service delivery standards and protocols on pre-
vention and management of unsafe abortion including
provision of comprehensive abortion care have been im-
plemented nationwide [7]. Despite the less-restrictive
legal environment, about 15 induced abortions per 1000
women of reproductive age are performed in the country
each year [8] and two-thirds of these are unsafe [5,9].
In Ghana, induced abortion complications account for
11% of maternal mortality nationwide [8], and up to 12%
of gynaecological admissions in leading public tertiary
hospitals [10,11]. These voluntary terminations of preg-
nancy are more common in urban areas and among
younger women [5,8,9]. Different methods are used for
these terminations. Recent evidence from one study, indi-
cated that over 80% of the women self-induced abortions
with misoprostol [11]. Misoprostol is a prostaglandin E1
analogue that is licensed for the treatment of peptic ulcer
disease. As a prostaglandin, it also causes uterine con-
tractions and cervical softening [12,13]. Misoprostol is
employed for labour and abortion induction based on
these effects. The declining complication and mortality
rates associated with induced abortions in some develop-
ing countries especially in Latin America have largely
been attributed to the widespread use of misoprostol
[3,12-15] and improved health care system [3].
With increasing popularity of misoprostol as an over
the counter self-administered abortifacient in Ghana [11],it is imperative that the morbidities associated with its
use are investigated. While most studies on induced abor-
tions have compared complications of spontaneous and
induced abortions, there is paucity of research on mor-
bidities associated with misoprostol-induced abortions.
This study aimed at comparing socio-demographic char-
acteristics and clinical complications associated with mi-
soprostol and non-misoprostol induced abortions among
patients admitted to Komfo Anokye Teaching Hospital
(KATH), Kumasi, Ghana.
Methods
This was a cross sectional study conducted at the gynae-
cological ward of KATH, a 1000-bed capacity hospital
and the second largest in the country. The hospital is
the main tertiary and referral health facility in the north-
ern sector of the country, serving seven out of the 10 re-
gions of the country. The Obstetrics and Gynaecology
Department of the hospital admits about 4,000 gynaeco-
logical cases each year.
The department has a comprehensive abortion care
unit which provides emergency services such as resusci-
tation, evacuation of the uterus, administration of oxyto-
cics, antibiotics, and analgesics. All clients are given
comprehensive post-abortion care including contracep-
tive counselling and offer of methods of their choice be-
fore they are discharged from the hospital. For all women
with abortion complications, the attending physicians ex-
plored and routinely documented the clinical history and
findings in the client clinical record. These included
among others the estimated gestational age, how the
index miscarriage started, the treatments sought and
medications taken before arrival in the hospital. Methods
used to initiate or induce abortion including the use of
misoprostol (‘cytotec’, the common name for misoprostol
in Ghana) were documented.
Additionally, during the peri-evacuation counselling, a
dedicated abortion care counsellor explored and docu-
mented the reproductive history of the woman. This in-
cluded how the index miscarriage occurred, fertility
desires of the woman and post-abortion contraception
choices. Thus the physician who provided emergency
clinical care of the woman, and the dedicated reproduct-
ive health counsellor are two main independent sources
of information on the type of miscarriage and the
methods of induced abortion employed.
All women who were admitted to the gynaecological
ward of KATH between June 15 and October 15, 2010
with a history or evidence of induced abortion were eli-
gible for inclusion into the study; women with spontan-
eous abortions were excluded. Each morning, the medical
records of all eligible women who had been treated and
were ready for discharge were reviewed by the research
team and gynaecological team responsible for the clients
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abortion. Eligible clients were then categorized into those
who had used misoprostol and those who had not used
misoprostol to induce abortion in the index pregnancy.
Every eligible client who admitted to using any other
method apart from misoprostol to induce abortion in the
index pregnancy and the next consecutive client who ad-
mitted to inducing abortion with misoprostol were se-
lected to participate in the study. Selected clients were
approached individually by a trained research assistant
(not involved in the care of the client), who explained the
purposes of the study to the client and sought her con-
sent to participate in the study. All consenting clients
underwent a confidential interview in Twi (vernacular)
or English using a pretested structured questionnaire
(Additional file 1). Where an eligible woman declined
consent/participation, the next eligible and consenting
client was recruited. The questions in the questionnaire
were not validated but were developed based on the re-
view of relevant current literature on induced abortions.
Pre-testing of the questionnaires was done by adminis-
tering draft copies to ten patients admitted with abortion
related complications at the University Hospital of the
Kwame Nkrumah University of Science and Technology
(KNUST) also located in the Kumasi metropolis. Neces-
sary corrections and modifications were made to obtain
the final questionnaire that was used in the data capture
during the survey.
Data were collected on client socio-demographic char-
acteristics, gynaecological and obstetric histories, whether
or not the miscarriage was induced, and if so, persons ini-
tiating abortion and method(s) of abortion induction
used. These questions were open ended to allow respon-
dents state various abortion induction methods employed.
Other information gathered were estimated gestational
age at the time of abortion and first point of call. The
morbidities and treatment associated with the current
admission were extracted from the clinical records. The
validity of the information given during the interview was
crosschecked with those documented in the medical
records.
Severe morbidity, the main outcome measure, was de-
fined as the presence in a client of one or more of the fol-
lowing; length of hospital stay more than 24 hours, need
for blood transfusion, parenteral antibiotics, laparotomy,
pyrexia (temperature ≥ 38°C), peritonitis, shock (blood
pressure at time of admission less than 90/60 mmHg)
and deranged renal or liver function tests [16-18]. All the
variables for severe morbidity were categorized as being
severe or not (i.e. binary outcome).
Using Epi Info version 3.5.1 (Centers for Disease Con-
trol and Prevention, Atlanta, USA), an estimated sample
size of 220 (110 in each group) had over 80% power to
detect a relative risk of 1.5 at 95% confidence level,assuming the ratio of misoprostol users to non-users is
unity and the prevalence of severe morbidity among non-
users of misoprostol is about 40% [17].
Data were double entered into database in Epi Info,
cleaned and transferred to Stata version 11.2 (Stata Corp,
College Station, Texas, USA) for statistical analyses. Cat-
egorical variables were compared using the Chi-square
(χ2) or Fisher’s exact tests as appropriate while continu-
ous variables were compared using student t-tests. Fac-
tors associated with severe morbidity were examined
using Poisson regression with robust error variance to
estimate crude and adjusted relative risks (RRs) with 95%
confidence intervals (CIs). This regression technique
allows for an unbiased estimate of the RR when the out-
come of interest occurs more than 10% of the time [19],
as was the case for severe morbidity in this analysis.
P < 0.05 was considered statistically significant. All miss-
ing values were excluded from the analyses.
Written permissions from the department of Obstetrics
and Gynaecology, KATH, to interview patients and ac-
cess their records were duly obtained. Indeed, these were
pre-requisites for ethical clearance Ref: CHRPE/82/09
which was obtained prior to commencement of the study
on September 4, 2009. The ethical approval was given by
the Committee on Human Research Publications and
Ethics of the Kwame Nkrumah University of Science and
Technology, Kumasi, Ghana.
Results and discussion
A total of 344 clients with induced abortion were admitted
to the gynaecological ward within the four-month study
period. Of these, 199 (57.9%) clients admitted to having
used misoprostol to induce their abortion. Overall, 126
misoprostol users and 126 misoprostol non-users who sat-
isfied the inclusion criteria were recruited into the study.
Seventy-three (i.e. 199–126) misoprostol users were not
recruited into the study; 72 of them were excluded by the
sampling strategy and the remaining one declined con-
sent. Also, 19 misoprostol non-users admitted during the
study period were discharged and left the ward before they
could be approached by the research team.
Table 1 compares the background characteristics of
misoprostol users and non-users. Misoprostol users were
more likely to be teenagers (p < 0.001), single (89.7% vs.
57.1%; p < 0.001), Christians (94.4% vs. 77.4%; p < 0001),
nulliparous (61.9 vs. 34.9%; p = 0.001), and to have com-
pleted at least basic (middle or junior high school) level
of education (81.5% vs. 61.9%; p = 0.001). They were less
likely to be in income-earning employments (27.9% vs.
50.9%; p < 0.001). However, the number of lifetime preg-
nancies was similar for misoprostol users and non-users
(p = 0.16).
The reasons for terminating pregnancy varied between
users and non-users of misoprostol (Table 2). Misoprostol
Table 1 Comparison of background characteristics of






N = 126 N = 126
n (%)* n (%)*
Age (years) < 0.001
<20 54 (42.9) 14 (11.1)
20+ 72 (57.4) 112 (88.9)
Mean (SD) 21.7 (4.9) 25.9 (6.8) < 0.001
Marital status < 0.001
Single 113 (89.7) 72 (57.1)




Less than basic 23 (18.6) 48 (38.1)
Basic education or higher 101 (81.5) 78 (61.9)
Religion§ < 0.001
Christian 119 (94.4) 96 (77.4)
Muslim 7 (5.6) 28 (22.6)
Occupation‡ < 0.001
Income earners 34 (27.9) 60 (50.9)
Non-income earners 88 (72.1) 58 (49.2)
Gravidity 0.16
Primigravid 40 (31.8) 30 (23.8)
Multigravid 86 (68.3) 96 (76.2)
Parity 0.001
Nulliparous 78 (61.9) 44 (34.9)
Parous 48 (38.1) 82 (65.1)
SD, standard deviation.
*Values are given as number (percentage) unless otherwise indicated.
†Basic education: Middle/Junior High School; 2 missing values in the
misoprostol users group.
§2 missing values in the misoprostol non-users group.
‡12 missing values (4 in misoprostol users and 8 in misoprostol
non-users group).
Table 2 Reasons for termination of pregnancy among
misoprostol users and non-users





N = 126 N = 126
n (%) n (%)
Wants to continue/still
schooling
36 (28.6) 10 (7.9) <0.001
No regular source of income
to support a family
26 (20.6) 8 (6.3) 0.001
Not in a stable relationship 34 (27.0) 35 (27.8) 0.90
Desire to limit family size 23 (18.3) 39 (31.0) 0.02
Medical reasons 4 (3.2) 3 (2.4) 0.90
Accidental medication - 4 (3.2) -
No reason stated 3 (2.4) 27 (21.4) <0.001
Damalie et al. BMC Women's Health 2014, 14:90 Page 4 of 8
http://www.biomedcentral.com/1472-6874/14/90users were more likely than non-users to undergo termin-
ation of pregnancy because they were in school or wanted
to continue schooling (p < 0.001) or they were not earning
regular income to support a family (p = 0.001). On the
other hand, significantly more non-users of misoprostol
than users cited no apparent reason for undergoing ter-
mination of pregnancy (p < 0.001) or did so because of
their desire to limit family size (p = 0.02). No statistically
significant differences were observed in terms of relation-
ship problems with male partners among users and non-
users of misoprostol.
Over two-thirds (70.6%) of clients reported that they
had self-induced abortions. About 1 in 10 abortions
(10.7%) were initiated by health workers (doctors or
pharmacists/dispensing technicians). While about 6.4%of clients reported that their abortions were initiated by
their male partners, 11.1% admitted that other relations
such as relatives, friends, school mates, and co-workers,
were the initiators. In 1.2% of the clients, the abortions
were initiated by traditional healers. More than two-
thirds (68.3%) of non-users of misoprostol used herbal
preparations, alcoholic beverages (such as Guinness For-
eign Extra Stout), sugar concoctions and some locally
prepared blood tonics as abortifacients. The identifiable
herbal preparations were commonly locally prepared
concoctions of leaves or barks of some plants in alcohol.
About 1 in 5 misoprostol non-users had instrumenta-
tion, mainly dilation and curettage or manual vacuum
aspiration. The remaining 11.1% of misoprostol non-
users took over-the-counter drugs (ergometrine or nor-
ethisterone enanthate tablets) to induce abortion.
Overall, 182 (72.2%) clients had severe morbidities
[79.4% misoprostol users vs. 65.1% non-users; (p = 0.01)]
(Table 3). However, comparing the individual categories
of severe morbidities, the differences between misopros-
tol users and non-users were not statistically significant
(all p-values > 0.05). The duration of admission ranged
from less than a day to 24 days (median duration 2 days;
interquartile range 1–4 days).
On univariable analysis, (Table 4), misoprostol users
were more likely to suffer severe morbidities compared
to non-users (unadjusted RR, 1.22; 95% CI, 1.04-1.43;
p = 0.01), as were teenagers compared to older women
(unadjusted RR, 1.17; 95% CI, 1.01-1.36; p = 0.04), single
compared to married women (unadjusted RR, 1.42; 95%
CI, 1.13-1.78; p = 0.003), and nulliparous compared to
parous women (unadjusted RR, 1.27; 95% CI, 1.09-1.48;
p = 0.002). The strongest predictor of severe morbidity
was the gestational age at which termination occurred
(p < 0.001).
On multivariable analysis (Table 5), the estimated gesta-
tional age at presentation (p < 0.001) and parity (adjusted
Table 3 Comparison of severe morbidities between






N = 126 N = 126
n (%) n (%)
Severe hemorrhage 46 (36.5) 34 (27.0) 0.10
Septicaemia 53 (42.1) 40 (31.8) 0.09
Deranged liver or kidney
function tests
10 (7.9) 4 (3.2) 0.17*
Laparotomy 1 (0.79) 2 (1.6) 1.00*
Prolonged hospital stay 74 (58.7) 60 (47.6) 0.08
Any severe morbidity 100 (79.4) 82 (65.1) 0.01
*Fisher’s exact test.
Table 4 Univariable analysis of association between
background characteristics and severe morbidities
Variable Severe
morbidity
Unadjusted RR p value





Misoprostol user 100 (79.4) 1.22 (1.04, 1.43)
Age (years) 0.04
<20 55 (80.9) 1.17 (1.01, 1.36)
20+ 127 (69.0) 1
Marital status 0.003
Single 145 (78.4) 1.42 (1.13, 1.78)









Christian 151 (71.6) 1
Muslim 31 (79.5) 1.11 (0.93, 1.33)
Occupation
Income earners 62 (66.0) 1 0.13
Non-income earners 110 (75.3) 1.14 (0.96, 1.36)
Gravidity 0.89
Primigravid 51 (72.9) 1.01 (0.85, 1.20)
Multigravid 131 (72.0) 1
Parity 0.002
Nulliparous 99 (81.2) 1.27 (1.09, 1.48)





<9 weeks 123 (71.9) 1
9-12 weeks 31 (63.3) 0.88 (0.70, 1.11)
>12 weeks 27 (93.1) 1.29 (1.13, 1.48)
RR, Relative risk; CI, Confidence interval.
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risk factors for severe morbidity. Nulliparous women
were 1.3 times more likely than parous women to suffer
severe post-abortion morbidity. Women who terminated
their pregnancies after 12 weeks’ gestation were about 1.4
times more likely to suffer severe morbidity than their
counterparts who induced abortions before nine weeks of
gestation (adjusted RR: 1.36; 95% CI: 1.18-1.57). There
was a significant linear trend towards suffering severe
morbidity with increasing gestational age (p trend = 0.02)
at which induced abortion occurred. There was no sig-
nificant association between misoprostol use and severe
morbidity among the women studied (p = 0.06).
The study compared the demographic and clinical
characteristics of misoprostol users and non-users among
clients admitted with induced abortion complications at
the second leading tertiary hospital in Ghana. Consistent
with characteristics of induced-abortion clients in Ghana
[8,9,11,20,21] and other countries [15,22], we found that
misoprostol users were younger, not married, nulliparous,
and had better educational background than non-users.
Gestational age at which pregnancy was terminated and
being nulliparous were independent risk factors for severe
morbidity following termination of pregnancy. The asso-
ciation between misoprostol use and severe morbidity
was not statistically significant.
About 60% of abortions in this study were induced with
misoprostol, confirming earlier reports that misoprostol
had become a popular and relatively cheap over the
counter abortifacient among women in Kumasi [11], and
possibly in Ghana. The figure is however, lower than 83%
reported earlier in the same centre [11], but much higher
than the 5-16% reported in the 2007 Ghana Maternal
Health Survey [8]. A number of reasons may account for
the higher proportion of misoprostol-induced abortions
in the study centre. Although the law on abortion in
Ghana is quite liberal and permits abortion under certain
circumstances, most physicians in public hospitals andespecially at the study centre are unwilling to initiate ter-
mination of pregnancies [8,23]. However, as a tertiary
centre clients who experience complications after seeking
abortion care elsewhere are likely to be referred for post-
abortion care.
About 90% of induced-abortions in this study were ini-
tiated by the clients themselves or unqualified or un-
trained persons. Such clients reported to this tertiary
facility when they encountered problems or complica-
tions [12,13,17,24]. Moreover, most terminations of preg-
nancies performed by qualified medical professionals











82 (65.1) 1 0.06
Misoprostol user 100 (79.4) 1.17 (0.99, 1.38)
Age (years) 0.88
<20 55 (80.9) 0.99 (0.83, 1.17)
20+ 127 (69.0) 1
Parity 0.004
Nulliparous 99 (81.2) 1.28 (1.08, 1.52)





<9 weeks 123 (71.9) 1
9-12 weeks 31 (63.3) 0.88 (0.70, 1.11)
>12 weeks 27 (93.1) 1.36 (1.18, 1.57)
RR, Relative risk; CI, Confidence interval.
aAdjusted for all variables in the table.
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tions [21] and will not be referred/report to KATH. The
difference in reported prevalence of self-induced abortion
could also be due to more under-reporting of clandestine
abortion procedures than abortions procured from med-
ical professionals [21]. Compared to the earlier study by
Konney et al. [11], both the number of clients with in-
duced abortions and the proportion of misoprostol-
induced abortions are lower in this study. As observed in
Brazil [12,15], it is conceivable that women in the study
area might have gained experience with the drug over
time resulting in usage of safer and more effective doses
and consequently fewer complications and admissions
arising from self-induced abortions with misoprostol.
More women who wanted to continue schooling or
were not earning income regularly resorted to using
misoprostol to induce abortion. To these non-income
earners misoprostol may be cheaper than other methods
of procuring induced abortion. The high prevalence of
self-induced abortion could be due to high level of social
stigma associated with abortion care in Ghana [5,9,21,23].
It could also be motivated by the fact that, by starting the
miscarriage the client can have access to health facilities
that do not offer elective abortion care. Additionally, the
clients with abortion complications can obtain emergency
care under the free maternity care programme of the Na-
tional Health Insurance Scheme (NHIS) which covers
abortion related complications but not elective termin-
ation of pregnancy. Thus, once misoprostol can be
acquired without prescription, women can procure andself-administer it to terminate pregnancies without pro-
fessional guidance or supervision [12,13,15,24].
On the other hand, for the non-users of misoprostol,
induced-abortions were mainly considered because they
did not want any more children or had no obvious rea-
sons for the termination. These reasons are consistent
with findings from other studies on induced abortions in
Ghana [8,9,20,21]. While we did not investigate contra-
ceptive use in this study, about 35% of married women
in Ghana have an unmet need for contraception [8].
Nearly three-quarters of women in this study had se-
vere morbidities. This is much higher than the 34% se-
vere complication rate reported by Rees et al. in South
Africa [16]. Though similar to the complication rate re-
ported in Cambodia [17], the rate is still unacceptably
high in a country with a non-restrictive abortion law.
Non availability of and poor access to safe abortion ser-
vices in most communities may contribute to the high
rate of severe morbidity in this study. For, even in the
context of a liberal legal regime, if accessibility to safe
abortion is limited, it would remain the case that
abortion-related morbidity would persist [5,6]. Almost all
the women had attempted termination of pregnancy ei-
ther by themselves or unqualified persons prior to report-
ing to this tertiary facility for the treatment of their
abortion-related complications. Notwithstanding the im-
plementation of the policy on comprehensive abortion
care, unsafe abortions continue to flourish due to a num-
ber of reasons. These may include slow translation of the
law into policy, service protocols and standards, limited
understanding of the law and its implications by many
communities and providers, ignorance of most Ghanaian
women about their legal rights to abortion and the reluc-
tance of most providers to offer elective abortion services.
For many women, safe abortion care is quite expensive as
the service is mainly offered by few private practitioners
who charge ridiculously high fees. Thus, cheaper alterna-
tives of inducing abortion such as the self – administra-
tion of misoprostol are easily adopted by the women with
unwanted pregnancy [5,6,11,23]. Accessibility to safe
abortion services is further hampered by the fact that only
treatment for abortion related complications, but not
elective abortions, is covered by the NHIS.
Generally, risk of complications associated with all
forms of abortion increases with gestational age, rising
exponentially after the first trimester, even when termi-
nations are performed under the best of circumstances
[25,26]. The risk is even higher when the abortions are
performed by individuals lacking the necessary skill or in
an environment that does not meet the minimum med-
ical standards. Although terminations after the first tri-
mester constitute the minority of abortion cases, they
account for the majority of serious abortion-related
complications including death, particularly in settings
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ing suggests that women who want to end unwanted
pregnancies should initiate the process early in the preg-
nancy to avoid experiencing severe morbidities.
In agreement with previous studies [28,29], we found
that women who had not given birth previously were at
increased risk of severe morbidity compared to their
parous counterparts. This is possibly because more nul-
liparous women tend to retain more products of concep-
tion compared to parous women, thereby increasing
their risk of severe morbidity [28].
Whereas some studies have reported reduced risks of
severe complication with misoprostol use compared to
other methods of inducing abortion [12,13,15], we did
not observe such an association. It is worth noting that
success or complications associated with using miso-
prostol to abort pregnancies depend on a number of
inter-related factors such as whether misoprostol is used
as a single agent or not, the dose, schedule, and route(s)
of administration as well as the gestational age at abor-
tion (including an accurate assessment of the same)
[12,13,15]. The effects of most of these additional factors
were not examined by this study.
The study has some limitations. Results from this
urban tertiary referral facility are not representative of
the general population. It is likely that women’s experi-
ence with and access to care for induced abortion and its
complications in rural settings will be different. Both the
estimates for induced abortions and the proportion of
misoprostol induced abortions are likely to be higher
than what was reported in the study due to misclassifica-
tion bias. In settings where induced abortion is stigma-
tized, women - especially those with complications - are
likely to report such incidents as spontaneous rather than
induced. However, this is likely to be minimal in this
study as questions on induced abortion were posed by
experienced physicians and counsellors involved in abor-
tion care. In addition, questions on the dose and routes
of administration of misoprostol, concurrent use of other
agents as well as contraceptive use were not included in
our study.
Further research is required to explore women’s mo-
tivation for using misoprostol as an abortifacient as well
as their experiences including the cost, accessibility,
safety, dosing regimens and the routes of administration.
There is also need to assess the long-term impact of the
use of misoprostol on complications related to induced
abortions.
Conclusion
Self-induced abortions using misoprostol is a common
practice among women in this study. Misoprostol users
were more likely to be young, single, nulliparous, un-
employed and of higher educational background thannon-users. Nearly three quarters of women with induced
abortions suffered severe morbidity. Nulliparous women
were at greater risk of suffering severe abortion related
morbidity than parous women. Nonetheless, severe mor-
bidity among misoprostol users and non-users did not
differ significantly but was directly related to the gesta-
tional age at which the induced abortions occurred.
Health education on the dangers of self-induced abor-
tions, appropriate use of medication abortion and the
provision of accessible and safe comprehensive abortion
care at early gestation could help reduce complications
associated with induced abortions in Ghana.
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